- Home
- CNSP vs PRSO Comparison
CNSP vs PRSO Comparison
Compare CNSP & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- PRSO
- Stock Information
- Founded
- CNSP 2017
- PRSO 2008
- Country
- CNSP United States
- PRSO United States
- Employees
- CNSP N/A
- PRSO N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- CNSP Health Care
- PRSO Technology
- Exchange
- CNSP Nasdaq
- PRSO Nasdaq
- Market Cap
- CNSP 4.0M
- PRSO 4.5M
- IPO Year
- CNSP 2019
- PRSO 2001
- Fundamental
- Price
- CNSP $6.19
- PRSO $0.86
- Analyst Decision
- CNSP Hold
- PRSO Strong Buy
- Analyst Count
- CNSP 1
- PRSO 1
- Target Price
- CNSP N/A
- PRSO $3.00
- AVG Volume (30 Days)
- CNSP 41.8K
- PRSO 112.9K
- Earning Date
- CNSP 08-14-2025
- PRSO 08-11-2025
- Dividend Yield
- CNSP N/A
- PRSO N/A
- EPS Growth
- CNSP N/A
- PRSO N/A
- EPS
- CNSP N/A
- PRSO N/A
- Revenue
- CNSP N/A
- PRSO $13,608,000.00
- Revenue This Year
- CNSP N/A
- PRSO $0.69
- Revenue Next Year
- CNSP N/A
- PRSO $35.21
- P/E Ratio
- CNSP N/A
- PRSO N/A
- Revenue Growth
- CNSP N/A
- PRSO 1.80
- 52 Week Low
- CNSP $4.93
- PRSO $0.52
- 52 Week High
- CNSP $221.94
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- CNSP 35.47
- PRSO 42.06
- Support Level
- CNSP $4.93
- PRSO $0.80
- Resistance Level
- CNSP $7.75
- PRSO $0.93
- Average True Range (ATR)
- CNSP 0.79
- PRSO 0.06
- MACD
- CNSP -0.08
- PRSO 0.01
- Stochastic Oscillator
- CNSP 37.06
- PRSO 46.31
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.